KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Finished Goods (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Finished Goods for 8 consecutive years, with $10.7 million as the latest value for Q1 2023.

  • Quarterly Finished Goods rose 25.14% to $10.7 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $10.7 million through Mar 2023, up 25.14% year-over-year, with the annual reading at $8.3 million for FY2022, 36.13% up from the prior year.
  • Finished Goods for Q1 2023 was $10.7 million at Biolife Solutions, up from $8.3 million in the prior quarter.
  • The five-year high for Finished Goods was $10.7 million in Q1 2023, with the low at $3.0 million in Q2 2019.
  • Average Finished Goods over 5 years is $7.3 million, with a median of $7.1 million recorded in 2020.
  • The sharpest move saw Finished Goods soared 334.26% in 2019, then dropped 9.84% in 2021.
  • Over 5 years, Finished Goods stood at $6.1 million in 2019, then grew by 10.56% to $6.7 million in 2020, then decreased by 9.84% to $6.1 million in 2021, then surged by 36.13% to $8.3 million in 2022, then increased by 29.48% to $10.7 million in 2023.
  • According to Business Quant data, Finished Goods over the past three periods came in at $10.7 million, $8.3 million, and $10.1 million for Q1 2023, Q4 2022, and Q3 2022 respectively.